Zobrazeno 31 - 35
of 35
pro vyhledávání: '"Font-Tello, Alba"'
Autor:
Dreijerink, Koen M. A., Groner, Anna C., Voc, Erica S.M., Font-Tello, Alba, Gu, Lei, Chi, David, Reyes, Jaime, Cook, Jennifer, Lim, Elgene, Lin, Charles Y., de laat, Wouter, Rao, Prakash K., Long, Henry W., Brown, Myles
While the multiple endocrine neoplasia type 1 (MEN1) gene functions as a tumor suppressor in a variety of cancer types, we explored its oncogenic role in breast tumorigenesis. The MEN1 gene product menin is involved in H3K4 trimethylation and co-acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd1ad1eea64de29fea4d9e23e42a7b75
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lazarian, Gregory, Yin, Shanye, Font-tello, Alba, Ten Hacken, Elisa, Sevastianik, Tomasz, Tom, Daniel, Regis, Fara Faye, Gill, Amy, Zheng, Mei, Georgopoulos, Katia, Neuberg, Donna S, Wang, Lili, Carrasco, Ruben D., Wu, Catherine J.
Publikováno v:
Blood; November 2018, Vol. 132 Issue: 1, Number 1 Supplement 1 p668-668, 1p
Autor:
Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Oncology Laboratory, Hospital La Paz Institute for Health Research, Madrid, Spain., Drier Y; Broad Institute of Harvard and MIT, Cambridge, MA, USA. yotam.drier@mail.huji.ac.il.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. yotam.drier@mail.huji.ac.il.; Lautenberg Center for Immunology and Cancer Research, Hebrew University, Faculty of Medicine, Jerusalem, Israel. yotam.drier@mail.huji.ac.il., Dreijerink KMA; Department of Endocrine Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.; Department of Internal Medicine, Amsterdam UMC, Amsterdam, the Netherlands., Brosens LAA; Department of Pathology, UMC Utrecht Cancer Center, Utrecht, the Netherlands., Deshpande V; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Epstein CB; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Conemans EB; Department of Endocrine Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.; Department of Internal Medicine, Amsterdam UMC, Amsterdam, the Netherlands., Morsink FHM; Department of Pathology, UMC Utrecht Cancer Center, Utrecht, the Netherlands., Graham MK; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Valk GD; Department of Endocrine Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands., Vriens MR; Department of Surgical Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands., Castillo CF; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Ferrone CR; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Adar T; Department of Gastroenterology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Bowden M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Whitton HJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Da Silva A; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Font-Tello A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Gaskell E; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Shoresh N; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Heaphy CM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sicinska E; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Kulke MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., Chung DC; Department of Gastroenterology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Bernstein BE; Broad Institute of Harvard and MIT, Cambridge, MA, USA. bernstein.bradley@mgh.harvard.edu.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. bernstein.bradley@mgh.harvard.edu., Shivdasani RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ramesh_shivdasani@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. ramesh_shivdasani@dfci.harvard.edu.; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA. ramesh_shivdasani@dfci.harvard.edu.
Publikováno v:
Nature medicine [Nat Med] 2019 Oct; Vol. 25 (10), pp. 1627.
- [1]
- « Předchozí
- 1
- 2
- 3
- 4